The benefits of pre-exposure prophylaxis vs. vaccines have been back on my mind since reading GiveWell’s Initial thoughts on malaria vaccine approval, which concluded that seasonal malaria chemoprevention (SMC) remains more cost-effective than vaccination at present (though it’s important to note that this vaccine is much lower-efficacy than the COVID ones, in part because taking down parasites is vaccination on hard mode).
The benefits of pre-exposure prophylaxis vs. vaccines have been back on my mind since reading GiveWell’s Initial thoughts on malaria vaccine approval, which concluded that seasonal malaria chemoprevention (SMC) remains more cost-effective than vaccination at present (though it’s important to note that this vaccine is much lower-efficacy than the COVID ones, in part because taking down parasites is vaccination on hard mode).